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about the likely catalytic mechanism of these enzymes
and explain the roles of a number of conserved residues
at the active site. This work also reveals that type IB
topoisomerases share structural homology with the four
tyrosine recombinases of known structure (Cre, XerD,
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in Yang and Mizuuchi, 1997). The type IB topoisomer-United Kingdom
ases and tyrosine recombinases share the same overall
fold in their z200 amino acid residue catalytic domain
and contain six conserved active site residues that are
Type I topoisomerases modify the topological state of
positioned in the same linear order within their polypep-
DNA by cleaving and rejoining one strand of a DNA tide chains. The overall reaction mechanism of these
duplex (reviewed in Wang, 1996). They function in DNA topoisomerase and recombinase families is essentially
replication, recombination, repair,and transcription, and
identical and involves cleavage of a single strand of a
mechanistically they fall into two major families, type IA
DNA duplex by nucleophilic attack of a conserved tyro-
and type IB. Emerging structural and biochemical work sine to give a 39 phosphotyrosyl protein±DNA adduct.
reveals a close functional relationship between type IB In the second rejoining step, a terminal 59 hydroxyl at-
topoisomerases and site-specific recombinases of the tacks the covalent adduct to release the enzyme and
phage lambda integrase family (here called tyrosine re- generate duplex DNA (Figure 1). Where the enzymes
combinases), and illustrates how enzymes with a con- differ is that topoisomerases cleave and then rejoin the
served catalytic domain can exhibit a range of different same 59 and 39 termini, whereas a site-specific recombi-
catalytic activities. Tyrosine recombinases, which are nase transfers a 59 hydroxyl generated by recombinase
found in bacteria and yeast, are distinguished from type cleavage to a new 39 phosphate partner located in a
I topoisomerases, because during recombination, a DNA different duplex region.
59 hydroxyl generated by recombinase-cleavage is re- What determines whether an enzyme will act preferen-
joined to a DNA strand of a distant or unconnected tially as a topoisomerase or as a recombinase? Many of
region of duplex; a complete recombination reaction the details of the reaction pathway for the recombinases
requires the coordinated participation of four recombi- are evident from the crystal structure of the Cre protein
nase molecules to break and rejoin the four strands complex with a pseudo-Holliday junction (Guo et al.,
of the two recombining duplex regions. In contrast, a 1997). From this structure we can see how the free 59
topoisomerase reaction can be mediated by a single hydroxyl terminus would be able to attack the phospho-
enzyme molecule. tyrosine adduct of a partner molecule in the recombina-
Common Structures and Mechanisms tion synapse and thus complete the reaction. For the
Despite the lack of detectable sequence homology be- topoisomerases, however, we do not yet have the equiv-
tween IB topoisomerases and tyrosine recombinases, alent structural insight for the intermediates between
there have been a number of observations that indicated strand cleavage and rejoining. One possibility is that
a link between these two classes of enzyme. The most there is a functional difference between the active sites
striking is that the mechanism of both enzyme families of the enzymes, while a second is that the effective
involves the formation of a covalent 39 phosphotyrosine multimeric state may, in part, be responsible. This latter
DNA±enzyme intermediate in a reaction that is indepen- view is supported by the structural studies that show a
dent of magnesium ions. Despite being considerably C-terminal oligomerization domain in the tyrosine re-
smaller than other type IB topoisomerases, the vaccinia combinases that is not conserved in the topoisomer-
enzyme contains a number of motifs conserved amongst ases. Furthermore, a body of evidence has shown that
type IB topoisomerases, suggesting conservation of a the type IB topoisomerases can act as monomers. In
common core structure. Furthermore, although first iden- contrast, a complete site-specific recombination strand
tified as a topoisomerase, the vaccinia enzyme has a exchange reaction requires theparticipation of four tyro-
strict site selectivity and can resolve Holliday junctions, sine recombinase protomers in order to break and rejoin
properties normally associated with recombinases rather four DNA phosphodiesters in a reaction in which each
than topoisomerases. This latter observation was partic- of the two pairs of strand exchanges are separated in
ularly interesting since several members of the tyrosine space and time. This requires a coordinated reciprocal
site-specific recombinase family show topoisomerase activation and inhibition of pairs of protein subunits that
activity under theappropriate conditions, giving tantaliz- appears to be controlled by interactions between pro-
ing hints that there might be more in common between tein monomers. This raises the question of whether we
the two classes of enzyme than the sequence analysis can regard topoisomerase activity simply as an uncou-
might suggest. pled recombinase waiting for a protein partner that never
The recent descriptions of the structures of a variety arrives? If so, then we might expect to find evidence for
of human topoisomerase I fragments complexed with a common basis to this activity in both enzyme families.
DNA (Redinbo et al., 1998; Stewart et al., 1998) and of Topoisomerase activity in both systems appears to
the catalytic core of the vaccinia virus topoisomerase be a stepwise process that leads to gradual relaxation.
Consequently, one can rule out any mechanism that(Cheng et al., 1998) have provided detailed information
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Figure 1. A Catalytic Mechanism for Type IB Topoisomerases and Tyrosine Recombinases
A complete cleavage-rejoining reaction proceeds in four steps. The initial protein±DNA complex (A) is converted to a stable covalent enzyme±
DNA adduct involving a 39 phosphotyrosine linkage at the active site (C), before completion of the reaction by rejoining of the DNA (A). The
reaction involves two similar transition states involving a pentavalent phosphate (B and D). Two arginine residues contact the oxygen atoms
of the scissile phosphate moiety and probably contribute to catalysis in two ways. The first is to promote nucleophilic attack on the phosphorus
atom (A and C above) due to an inductive effect upon the electrons around it, while the second is to stabilize the charge that develops on
these oxygens in the transition states (B and D). Consequently, these residues substitute for the role played by the magnesium ion(s) in many
other phosphoryltransferases. In this mechanism two additional residues each work reciprocally as acids/bases during catalysis (defined as
ªacidº and ªbaseº on the basis of their protonation state in [A]). One residue (labeled ªbaseº above) serves alternately to increase the
nucleophilicity of the attacking tyrosine (A) and then to reprotonate it (D), while the other (labeled ªacidº above) acts in a similar fashion upon the
attacking 59 hydroxyl (C) and phosphodiester oxygen (B), respectively. The same general scheme can be applied to catalysis on ribonucleoside-
containing substrates.
It has been proposed that during catalysis the proton of the tyrosine nucleophile could be transferred to a water molecule, which would be
acting as the ªbaseº (Stewart et al., 1998). Alternatively, this ªbaseº could be an appropriately positioned histidine in Cre (Guo et al., 1997)
and other tyrosine recombinases. However, the equivalent residue is always a lysine in IB topoisomerases. This substitution could explain
the difference in activity between the proteins as lysine would presumably be much more effective than histidine at increasing the nucleophilicity
of the tyrosine, although it should be noted that there is only a subtle difference between full proton transfer and stabilization of an oxyanion
via a hydrogen bond. A similar argument could explain the fact that a potential ªacidº is a tryptophan in Cre, but is a histidine in most other
tyrosine recombinases and in topoisomerases. The role of a conserved lysine in a b hairpin present in all of the determined recombinase and
topoisomerase structures remains unclear, although its mutation leads to a dramatic loss of catalytic activity.
allows free rotation of the DNA duplex after cleavage. the topoisomerases. That being said, such a mechanism
could explain the observation that binding of recombi-Complete control could be achieved by a ªstrand pas-
sageº mechanism such as that suggested for the type nase molecules adjacent to each other on DNA inhibits
topoisomerase activity even in the absence of synapsis,IA topoisomerases (Lima et al., 1994). An alternative
mechanism is proposed for the human topoisomerase, as if protein±protein interactions prevent rotation of the
duplex about the cleavage site.that involves a limited release, and hence rotation, of
the DNA on one side of the nick site resulting in stepwise One intriguing possibility, which could explain whether
an enzyme functions preferentially as a topoisomeraserelaxation (Stewart et al., 1998). However, it is difficult
to understand at the molecular level how the changing or as a recombinase, is that the favorability and mecha-
nism of the catalytic activation step determines whethersurface of the DNA duplex that would be presented to
the enzyme could be restrained effectively by such a strand cleavage and religation are tightly coupled to
synapsis. In the vaccinia topoisomerase structure, themechanism. Also, this mechanism does not explain why
recombinases are such poor topoisomerases since they active site tyrosine side chain is not positioned correctly
for catalysis within the active site, yet in the humanmake even fewer contacts adjacent to the nick site when
bound as a monomer to DNA than those observed for enzyme complexed with DNA this side chain (although
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mutated to phenylalanine to prevent catalysis) is now that is cleaved in normal recombination. In this case the
reaction did not require the Flp active site tyrosine andpositioned ideally to attack the phosphate. This situation
is assumed to have occurred by a RNase A±like mecha-is repeated in the XerD crystal structure, where the tyro-
nism involving the direct attack of the ribose 29 hydroxylsine nucleophile is inappropriately positioned for nucleo-
onto the 39 phosphodiester. The mechanism that limitsphilic attack, when compared to the other recombinase
the recombination activity of Flp to a specific phospho-structures. It has been suggested that the activation of
diester, while allowing the RNase activities to be di-the recombinases involves a conformational change at
rected to two adjacent phosphodiesters, is unclear. Itthe C terminus of the protein that moves the active
would not appear to be a consequence of limitationssite tyrosine into position ready to attack the scissile
on active site tyrosine positioning within the enzymephosphate (Subramanya et al., 1997). This conforma-
because exogenous nucleophiles, such as tyramine, re-tional change could either be triggered by binding to
tain cleavage specificity for the ªnormalº phosphodies-DNA or more likely, in the case of the recombinases, by
ter. Furthermore, the mechanism that limits direct attackinteractions between protein monomers during syn-
of a ribose 29 hydroxyl onto the phosphodiester oneapsis.
nucleotide downstream of the normal scissile phos-Novel Catalytic Activities
phate is not evident, though ribonucleoside positioningThe conserved active sites of type IB topoisomerases
may be important. The apparent ability of Flp active siteand tyrosine recombinases exhibit a substantial catalytic
residues toactivate adjacent phosphodiesters demandsflexibility. The catalog of different reactions catalyzed by
surprising flexibility between those parts of the proteinthese enzymes has beenextended by thedemonstration
and DNA involved in sequence-specific interactions andthat vaccinia topoisomerase and Flp recombinase not
those involved in catalysis. Though the structure of Flponly have RNase activity, but are able to catalyse one-
is unknown, it is likely that its catalytic mechanism andstep cleavage and rejoining reactions that do not require
structure are very similar to those of the other tyrosinethe participation of covalent protein±DNA intermediates
recombinases.(Sekiguchi and Shuman, 1997; Shuman, 1998 [April issue
Type IB topoisomerases and tyrosine recombinasesof Molecular Cell]; Xu et al., 1998 [April issue of Molecu-
are able to utilize nucleophiles other than the normallar Cell]). All of these reactions require the participation
tyrosine, the normal DNA 59 hydroxyl and a ribonucleo-of conserved active site residues implicated inphospho-
side 29 hydroxyl. For example, exogenous phenolatediester activation.
and peroxide nucleophiles can substitute for the activeRNase activity of vaccinia topoisomerase I and Flp
site tyrosine of Flp in a DNA strand cleavage reaction,was detected in duplex DNA substrates containing a
and enzymes of both families can mediate alcoholysissingle ribonucleoside immediately 59 of the normal scis-
and hydrolysis reactions on the 39 phosphotyrosinesile phosphate. Attack of the active site tyrosine gener-
bond of a covalent protein±DNA intermediate, thus mim-
ates a 39 phosphoprotein that is now attacked by the
icking attack by the terminal DNA 59 hydroxyl in strand
29 hydroxyl of the adjacent ribonucleoside, rather than
rejoining (Knudsen et al., 1997). Furthermore, vaccinia
the normal terminal DNA 59 hydroxyl, to give a 29,39
topoisomerase and a type II topoisomerase, E. coli topo-
cyclic phosphate and a terminal DNA 59 hydroxyl. With isomerase IV, have been converted to endonucleases
vaccinia topoisomerase the terminal cyclic phosphate by mutating the active site tyrosine nucleophile to gluta-
is released as product, whereas Flp appears to mediate mate and histidine, respectively (Wittschieben et al.,
hydrolysis of the cyclic phosphate to a terminal 39 ribo- 1998; Yokochi et al., 1996); presumably these new resi-
nucleoside phosphate, as does pancreatic RNase A in dues act as general bases facilitating the attack of water.
a similar phosphoryl transfer reaction. Vaccinia topo- These results demonstrate that a covalent protein±
isomerase can rejoin the 29,39 cyclic phosphate to the nucleotide intermediate is not mandatory for catalysis
59 hydroxyl, thereby reconstituting the original duplex of phosphodiester cleavage or rejoining by these en-
substrate, by two distinct pathways. The more efficient zymes. In a complementary way, endonuclease NaeI
reaction, which requires the active site tyrosine, pro- can be transformed into a topoisomerase by a single
ceeds by a two-step reversal of the initial cleavage reac- amino acid change that creates an active site with DNA
tion. A less efficient one-step rejoining reaction was rejoining activity (Jo and Topal, 1995).
catalyzed by an enzyme in which the active site tyrosine Taken together, the structural and biochemical work
was mutated to phenylalanine. In this reaction, a direct leads to a mechanistic framework for understanding
attack of the terminal DNA 59 hydroxyl on the the 29,39 how the catalytic activities of topoisomerases and tyro-
cyclic phosphate regenerated the original duplex sub- sine recombinases are related to those of other enzymes
strate. This second reaction has parallels with reactions that cleave and rejoin nucleic acid phosphodiester
in which pancreatic RNase A and RNA ligase can join bonds, and how they could have evolved from a com-
a 59 hydroxyl to a 29,39 cyclic phosphate, though in the mon ancestor. They also demonstrate how a common
latter case the product has a 29,59 phosphodiester link- catalytic phosphodiester activation domain can utilize
age. In contrast, conventional DNA/RNA ligases operate different substrates and nucleophiles inorder tomediate
by a completely different mechanism in which a 39 hy- different biochemical functions.
droxyl attacks an activated 59 adenylate that requires Biological Function and Evolutionary Implications
the prior transfer of an AMP moiety from an ATP or NAD Does the RNase activity of topoisomerases and tyrosine
cofactor to an enzyme active site lysine. recombinases have any functional significance? Shu-
Flp action on a substrate containing a ribonucleoside man (1998) has suggested that DNA containing ribonu-
39 of the normal phosphodiester cleavage site revealed cleosides may be a physiologically relevant substrate
a second distinct RNase activity which is directed at for type IB topoisomerases, which could operate a sur-
veillance mechanism for removing ribonucleosides fromthe phosphodiester immediately downstream of the one
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DNA, or indeed mediate RNA recombination. Alterna-
tively, these enzymes may normally act only on DNA,
their flexible active site being required by the catalytic
mechanism, or simply being a fortuitous consequence
of evolution. The active site could be an ancient relic of
early proteins that catalyzed phophoryl transfer reac-
tions. During the transition from a putative ªRNA worldº
to one involving intimate interplay between RNA and
DNA, early protein enzymes may well have exploited the
29 hydroxyl of ribonucleosides as a nucleophile in strand
transfer reactions involving RNA±DNA hybrids. As tyro-
sine became a protein constituent, the ribonucleoside
nucleophile could be replaced, thereby allowing an en-
zyme to process DNA in the absence of RNA.
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